|
64 Companies |
|
21 Products |
|
21 Products |
|
23 Mechanisms of Action |
|
221 Trials |
|
11162 News |
|
| «12...130131132133134135136137138139140141142 |
- | Benlysta (belimumab) / GSK
New P2 trial: The Evaluation of Belimumab in Myasthenia Gravis (MG) (clinicaltrials.gov) - Nov 27, 2011
P2, N=42, Recruiting, Sponsor: GlaxoSmithKline
- | Soliris (eculizumab) / AstraZeneca
Enrollment change: Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis (clinicaltrials.gov) - Nov 16, 2011
P2, N=14, Completed, Sponsor: Alexion Pharmaceuticals
N=24 --> 14
- | Soliris (eculizumab) / AstraZeneca
Trial completion: Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis (clinicaltrials.gov) - Nov 16, 2011
P2, N=14, Completed, Sponsor: Alexion Pharmaceuticals
N=24 --> 14 Active, not recruiting --> Completed
- Clinical: Perception and Multisensory Integration in Neurological Patients Using fMRI (clinicaltrials.gov) - Oct 31, 2011
P=N/A, N=30, Not yet recruiting, Sponsor: Hadassah Medical Organization
- | prednisone / Generic mfg.
Enrollment change: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (clinicaltrials.gov) - Oct 18, 2011
P3, N=150, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed N=200 --> 150
- Benlysta (belimumab) / GSK
New P2 trial, IO biomarker: A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects with Generalized Myasthenia Gravis (MG) (EUDRACT) - Oct 4, 2011
P2, N=6, Ongoing, Sponsor: GlaxoSmithKline Research & Development Limited